SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background and aims: Inflammatory bowel disease (IBD) is initiated and perpetuated by a dysregulated immune response to unknown environmental antigens such as luminal bacteria in genetically susceptible hosts. SR-PSOX/CXCL16, a scavenger receptor that binds phosphatidylserine and oxidised lipoprotein, has both phagocytic activity and chemotactic properties. The aim of this study was to investigate the role of SR-PSOX/CXCL16 in patients with IBD and experimental murine colitis. Methods: The serum levels of SR-PSOX/CXCL16 were measured in patients with IBD. The roles of SR-PSOX/CXCL16 in phagocytosis of bacterial components and cytokine production by macrophages from wild-type (WT) and SR-PSOX/CXCL16 knockout (KO) mice were assessed. Colitis was induced by administering dextran sulfate sodium (DSS) to WT and SR-PSOX/CXCL16 KO mice. Colonic inflammation was analysed by clinical, histological and immunological parameters. Finally, the effect of a monoclonal antibody (mAb) to SR-PSOX/CXCL16 on DSS-induced colitis and trinitrobenzene sulfonic acid-induced colitis models was evaluated. Results: Serum levels of SR-PSOX/CXCL16 correlated significantly with the disease activity of patients with IBD. Ex vivo experiments showed that SR-PSOX/CXCL16 was involved in both phagocytosis of bacterial antigens and the T helper 1 immune response through the production of interleukin 12 and interferon γ. In vivo murine experiments demonstrated the upregulated gene expression of SR-PSOX/CXCL16 in inflamed colonic tissues and the predominant expression of SR-PSOX/CXCL16 on macrophages. SR-PSOX/CXCL16 KO mice were less susceptible to colonic inflammation than were their WT littermates. Administration of SR-PSOX/CXCL16 mAb ameliorated the condition in the two different experimental colitis models. Conclusions: SR-PSOX/CXCL16 plays a critical role in colonic inflammation and could be a potential therapeutic target for patients with IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sellon, R. K., Tonkonogy, S., Schultz, M., Dieleman, L. A., Grenther, W., Balish, E., Rennick, D. M., & Sartor, R. B. (1998) · Infection and Immunity · doi:10.1128/iai.66.11.5224-5231.1998 · Cited by 1,483
The genetics and immunopathogenesis of inflammatory bowel disease
Cho, J. H. (2008) · Nature Reviews Immunology · doi:10.1038/nri2340 · Cited by 940 · cited 11×
“Previous clinical and basic observations suggest that inflammation is initiated and perpetuated by a dysregulated immune response to unknown environmental antigens such as luminal bacteria in genetically susceptible hosts.1 Recent genome-wide association studies showed that genes involved in both innate and adaptive i…”
BackgroundInfluentialA protective function for interleukin 17A in T cell–mediated intestinal inflammation
O'Connor Jr, W., Kamanaka, M., Booth, C. J., Town, T., Nakae, S., Iwakura, Y., Kolls, J. K., & Flavell, R. A. (2009) · Nature Immunology · doi:10.1038/ni.1736 · Cited by 756
Cited by
Scavenger Receptor Structure and Function in Health and Disease
Zani, I., Stephen, S., Mughal, N., Russell, D., Homer-Vanniasinkam, S., Wheatcroft, S., & Ponnambalam, S. (2015) · Cells · doi:10.3390/cells4020178 · Cited by 361
The Role of CXCL16 in the Pathogenesis of Cancer and Other Diseases
Korbecki, J., Bajdak-Rusinek, K., Kupnicka, P., Kapczuk, P., Simińska, D., Chlubek, D., & Baranowska-Bosiacka, I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073490 · Cited by 161
“CXCL16 can also be taken as a marker of inflammatory bowel disease (IBD) [63].”
BackgroundDuodenal microbiota composition and mucosal homeostasis in pediatric celiac disease
Cheng, J., Kalliomäki, M., Heilig, H. G., Palva, A., Lähteenoja, H., de Vos, W. M., Salojärvi, J., & Satokari, R. (2013) · BMC Gastroenterology · doi:10.1186/1471-230x-13-113 · Cited by 152
Toyonaga, T., Matsuura, M., Mori, K., Honzawa, Y., Minami, N., Yamada, S., Kobayashi, T., Hibi, T., & Nakase, H. (2016) · Scientific Reports · doi:10.1038/srep35014 · Cited by 75
Self-citationFaecal microRNAs: indicators of imbalance at the host-microbe interface?
Moloney, G. M., Viola, M. F., Hoban, A. E., Dinan, T. G., & Cryan, J. F. (2018) · Beneficial Microbes · doi:10.3920/bm2017.0013 · Cited by 65
Metadata
- Authors
- Uza, N., Nakase, H., Yamamoto, S., Yoshino, T., Takeda, Y., Ueno, S., Inoue, S., Mikami, S., Matsuura, M., Shimaoka, T., Kume, N., Minami, M., Yonehara, S., Ikeuchi, H., & Chiba, T.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2011-04-06
- Volume
- 60
- Issue
- 11
- Pages
- 1494-1505
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2170260989
- Cited by
- 43
- References
- 3
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation. https://app.cochat.ai/papers/10.1136/gut.2010.221879
- The paper
- Uza, N., Nakase, H., Yamamoto, S., Yoshino, T., Takeda, Y., Ueno, S., Inoue, S., Mikami, S., Matsuura, M., Shimaoka, T., Kume, N., Minami, M., Yonehara, S., Ikeuchi, H., & Chiba, T. (2011). SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation. Gut. https://doi.org/10.1136/gut.2010.221879
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.